Haisco Lilly Collaboration | Lucid Diligence Brief
Haisco’s Lilly Deal Tests China-Originated Small-Molecule Discovery…
Lucid Diligence Brief: Insilico and Human Longevity collaboration
Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines…
Lucid Diligence Brief: ERS Genomics and Aurigene CRISPR/Cas9 License
Lucid Diligence Brief: ERS Genomics’ CRISPR/Cas9 IP license to Aurigene raises…
Lucid Diligence Brief: Anthropic acquires Coefficient Bio
Lucid Diligence Brief: Anthropic acquires Coefficient Bio Professional…
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B…
Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide licensing agreement
Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide…
Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic editing to siRNA obesity therapies
Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic…
Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration
Lucid Diligence Brief: Iambic Takeda AI drug discovery collaboration…
Lucid Diligence Brief: Chai Discovery and Eli Lilly biologics AI collaboration
Lucid Diligence Brief: Chai Discovery and Eli Lilly biologics AI collaboration…
Lucid Diligence Brief: Sinopia Biosciences receives NIGMS grant for LEADS platform
Lucid Diligence Brief: Sinopia Biosciences receives NIGMS grant for LEADS…
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…